Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C28H24N4O2 |
| Molecular Weight | 448.5158 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=C(C=CC=C2)C(=N[C@H](NC(=O)C3=CC4=C5N3CCCC5=CC=C4)C1=O)C6=CC=CC=C6
InChI
InChIKey=CZPILLBHPRAPCB-AREMUKBSSA-N
InChI=1S/C28H24N4O2/c1-31-22-15-6-5-14-21(22)24(18-9-3-2-4-10-18)29-26(28(31)34)30-27(33)23-17-20-12-7-11-19-13-8-16-32(23)25(19)20/h2-7,9-12,14-15,17,26H,8,13,16H2,1H3,(H,30,33)/t26-/m1/s1
| Molecular Formula | C28H24N4O2 |
| Molecular Weight | 448.5158 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Melatonin and its precursor, L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro. | 2004-04 |
|
| CCK regulates pancreatic enzyme secretion via short duodenal-pancreatic reflexes in pigs. | 2003-02 |
|
| Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. | 2000-03-10 |
|
| Effects of intraduodenal administration of tarazepide on pancreatic secretion and duodenal EMG in neonatal calves. | 1998-11-30 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:16:18 GMT 2025
by
admin
on
Mon Mar 31 18:16:18 GMT 2025
|
| Record UNII |
RK2972YZ2U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C547
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB10832MIG
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
C76465
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
DB06435
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
DTXSID101350940
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
RK2972YZ2U
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
7008
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
10343641
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
141374-81-4
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
100000082405
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
C118031
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
CHEMBL1742455
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|